Promotional drug litrature.pptx slides mbbs

Promotional drug litrature.pptx slides mbbs

1. Promotional drug literature

2. Drug promotional literatures (DPLs) are used as a promotional tool to advertise new drugs entering the market to doctors. Large number of new drugs are introduced into the market every day. Pharmaceutical companies use drug promotional literatures (DPLs) as a major marketing tool to promote their new drugs.

3. Pharmaceutical industry in the USA spends more than 30 billion dollars in marketing and promoting to enlighten the clinicians about their products. About 50% of budget is spent on training MR 90% of physicians will see MR( medical representatives) MR emphasize only on positive aspect and neglecting the ADR

4. Importance DPLs should provide vital drug information and utilized to convince health professionals to prescribe the new drug. Many a times, it is the only source on which treating physicians depend on for updating their knowledge about the existing and novel drugs Such marketing influences clinician's prescribing behavior with or without benefitting the patient.

5. Drug promotional companies are more involved in establishing a commercial relationship with the treating physicians wherein ethical and educational aspect is compromised.   WHO has laid down ethical criteria for medicinal drug promotion and has recommended pharmaceutical industries to implement these guidelines

6. World Health Organization (WHO), medicinal drug promotion is defined as “all informational and persuasive activities by manufactures and distributors, the effect of which is to induce the prescription, supply, purchase, and/or use of medicinal drugs. Hence, the treating physicians should learn the art of analyzing DPL to provide quality care for the patients .

7. Ethical criteria for medicinal drug promotion (WHO 1988) International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) Code of Practice (2012) Organization of Pharmaceutical Producers of India (OPPI) Code of Pharmaceutical Practices(2007).

8. Good Promotional Criteria Good Promotional Criteria Product claim must identify the drug’s brand & generic names in a proportionate ratio. Pictorial illustrations must be relevant & scientific. Shouldn’t make any claims like “Magical remedy” or “Only cure”.

9. Should contain risks & benefits of the drug. Supported by substantial evidences or clinical experiences. Mention cost properly and the address of the manufacturer & date of production. Information about Adverse Drug Reactions, drug interactions and precautions

10. Unsubstantiated claims, Catchy phrases, Irrelevant Pictures, Charts & Tables shouldn’t be there. Should inform, educate, stimulate and direct the reader in the simplest and most concise manner. Promotional brochures should give importance to brief prescription information (BPI). Focused, attention-grabbing and benefits-driven.

11. Advantages Introduces a new product in the market Increases prospects & sales. Fights competition & Eliminates middlemen. Educates the target market. Raises the standard of living .

12. Disadvantages May be inadequate, inaccurate, invalid, unethical, false, misleading, biased, and deceptive or based on studies of poor methodological quality. Leads to monopoly, Creates artificial demand. Increases the price of the product. Enhances the self medication of patients & May be harmful for the society .

13. WHO criteria to be followed by pharmaceutical industries for the DPL 1 .The names of the active ingredients using either international nonproprietary names or the approved generic names of the drug 2. The brand name 3. Content of active ingredient per dosage form or regimen 4. Name of other ingredients known to cause problems, i.e., adjuvant 5. Approved therapeutic uses 6. Dosage form or regimen 7. Side effects and major adverse drug reaction 8. Precautions, contraindications, and warnings 9. Major interactions 10. Name and address of the manufacturer or distributor 11. Reference to scientific literature as appropriate.